Item 7.01. Regulation FD Disclosure.

On April 18, 2022, ProKidney LP ("ProKidney") announced that, in connection with the previously announced business combination with Social Capital Suvretta Holdings Corp. III ("SCS"), ProKidney and SCS will host a joint analyst day on April 28, 2022 (the "Analyst Day").

The Analyst Day will begin at 8:00 a.m. Eastern Time on April 28, 2022.

A copy of the materials to be presented at the Analyst Day is attached hereto as Exhibit 99.1, and is incorporated herein by reference. In addition, a live webcast of the Analyst Day will be available on the ProKidney and SCS websites at www.prokidney.com and www.socialcapitalsuvrettaholdings.com/dnac.

In accordance with General Instruction B.2 of Form 8-K, the information in Item 7.01 and in Exhibit 99.1 of this Current Report on Form 8-K is being furnished and shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing. In addition, the furnishing of this Item 7.01 of Form 8-K and Exhibit 99.1 will not be deemed an admission that such information includes material information that is not otherwise publicly available.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

The following is furnished as an exhibit to this report:



Exhibit
  No.        Description

99.1           ProKidney LP and Social Capital Suvretta Holdings Corp. III Analyst
             Day Presentation, dated as of April 28, 2022

104          Cover Page Interactive Data File (embedded within the Inline XBRL
             document)



                                      -2-

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses